Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination vaccines
Biotech
Moderna flu vaccine beats approved competitor in fresh ph. 3 win
The long and winding journey of Moderna’s mRNA flu vaccine toward regulators has come one step closer with a phase 3 win over an approved competitor.
James Waldron
Jun 30, 2025 8:05am
Moderna's next-gen COVID vax surpasses approved version in ph. 3
Mar 26, 2024 10:55am
Moderna's one-two COVID-flu punch matches existing vaccines
Oct 4, 2023 9:55am
After initial stumbles, Moderna gets clean win for mRNA flu shot
Sep 13, 2023 6:30am
Vaccine combo hits back at treatment-resistant cancer
Jun 23, 2022 11:01am
AstraZeneca starts phase 1 of COVID-19 antibodies
Aug 25, 2020 7:35am
